The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular ...

Microlenses applied to eyeglasses can help reduce growth-related worsening of nearsightedness (myopia), preventing potential ...